{
    "answer": "Cosentyx's net sales in the immunology segment for the full year 2024, reported in common currency, were $5,509 million, representing a 12% increase compared to the full year 2023. In constant currency, this was $5,432 million, representing a 9% increase compared to the full year 2023. The change from full year 2023 to 2024 was a $1,079 million ($5,509M - $4,430M) or 25.1% increase, assuming a 1:1 currency conversion rate for the quick-acting calculation.",
    "ground_truth": "$6,141,000,000; 23% increase (reported); 25% increase (constant currency)",
    "rewards": [
        0,
        0,
        0,
        0,
        0,
        0,
        0
    ],
    "reward_sum": 0,
    "turns": 7,
    "search count": 4,
    "script count": 0,
    "summary count": 1,
    "context lengths": [
        923,
        3075,
        3704,
        5286,
        6651,
        8657,
        1752
    ]
}